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What does this study add? 
This is the first prospective study to test if a biomechanical assessment of abdominal aortic 
aneurysm at baseline predicts future events. We show that the aneurysm biomechanical ratio 
of wall stress to wall strength is independently associated with future aneurysm rupture and 
repair, after incorporating known risk factors such as diameter. The methods used are robust 
and determining the aneurysm biomechanical ratio could be a useful adjunct to diameter and 





Objectives Improved methods of rupture prediction is a priority in abdominal aortic 
aneurysm (AAA). Biomechanical analysis of risk in AAA has major clinical potential but 
lacks robust evidence that it adds clinical value. We aimed to test if the aneurysm 
biomechanical ratio (ABR, a dimensionless ratio of wall stress and wall strength) can predict 
aneurysm-related events. 
Methods In a prospective multicentre clinical study of 295 patients with AAA (diameter ≥ 40 
mm), we used three-dimensional reconstruction and computational biomechanical analyses to 
compute ABR at baseline. Participants were followed for at least two years and the primary 
endpoint was the composite of aneurysm rupture or repair.  
Results The majority were male (87%) current or former smokers (86%), most (72%) had 
hypertension (mean systolic blood pressure of 140±22 mmHg) and mean baseline diameter 
was 49.0±6.9 mm. Mean ABR was 0.49±0.27. Rupture (n=13) or repair (n=102) occurred in 
115 (41%) cases. The number of repairs increased across tertiles of ABR; low (n=24), 
medium (n=34), high ABR (n=44) (p=0.010). Rupture or repair occurred more frequently in 
those with higher ABR (log rank p=0.009) and ABR was independently predictive of this 
outcome after adjusting for diameter and other clinical risk factors, including gender and 
smoking (hazard ratio, 1.41; 95% confidence interval, 1.09-1.83; p=0.010).  
Conclusions We have shown that the biomechanical ABR is a strong independent predictor 
of AAA rupture or repair in a model incorporating known risk factors, including diameter. 
Determining ABR at baseline could help guide the management of patients with AAA. 
 







Abdominal aortic aneurysm (AAA) rupture is associated with up to 90% mortality and only 
50-70% of those who reach hospital survive.1 Given the typically asymptomatic nature of 
AAAs, most are found incidentally or through screening studies.2 When detected, pre-
emptive surgical repair is usually offered when the maximum anterior-posterior aneurysm 
diameter reaches 50-55 mm. However, despite the strong association between diameter and 
risk of rupture,3-5 there remain cases that rupture at smaller diameters6 (especially in women7) 
and cases that grow large despite never rupturing.8 In fact, for those with aneurysm greater 
than 55 mm the risk of death from causes other than AAA is higher than the risk of death 
from rupture.9 This uncertainty has stimulated interest in alternative methods to identify cases 
that are more likely to rupture, and hence benefit from surgical intervention.  
 
One approach is the biomechanical assessment of AAA stability using calculations of wall 
stress with the finite element method. Computational methods have now progressed to the 
point of semi-automated analyses.10,11 Many reports describe the possible clinical benefit of 
peak wall stress (PWS)12-16 and the use of a dimensionless ratio of wall stress and wall 
strength.10,17,18 Yet, despite such metrics being noted in clinical guidelines as factors that 
influence rupture,19 there is a clear lack of evidence to support their use.20 Data thus far have 
been limited by factors ranging from small sample sizes to the non-standardised and arbitrary 
methods used to calculate wall stress. Consequently, a systematic review of the literature 
established that none of the proposed biomechanical imaging markers are conclusively 
associated with growth or rupture.21  
 
We reported a new method22 to compute wall stress in AAAs that overcomes the obstacles of 
requiring unattainable patient-specific material properties while also incorporating 
  
5 
measurements of wall thickness.11 Our hypothesis is that this new approach will provide 
more patient-specific calculations of risk and be a better predictor of clinical outcome than 
diameter. To test this, we applied our technique in a prospective study to determine if patient-
specific aneurysm biomechanical ratio (ABR, i.e. the dimensionless ratio of wall stress and 
wall strength) at baseline predicts the combined outcome of aneurysm rupture and/or repair. 
 
Methods 
This study is reported in line with the STROBE statement23 and a detailed description of the 
Methods, along with the STROBE checklist (Table S1) are available in the Supplementary 
Material. 
 
Study design, setting and population 
This was a multicentre cohort study performed as part of the MA3RS Study 
(ISRCTN76413758).24,25 All patients gave informed consent and were selected based on 
AAA diameter ≥ 40 mm measured by ultrasound and under ultrasound surveillance as part of 
routine care. A full description of inclusion/exclusion criteria is provided in the 
Supplementary Material. 
 
Study protocol and follow-up 
Within six weeks of the initial screening ultrasound, participants underwent full clinical 
assessment, including blood pressure measurement, MRI and computed tomography 
angiography (CTA). Patients were then reviewed every six months for a minimum of 24 
months. The full protocol is available elsewhere.25 Briefly, patients were imaged using a 3T 
Siemens Magnetom Verio scanner using a respiratory-gated, T2-weighted (T2W) turbo spin 
echo sequence (TR/TE 2500/252 ms; matrix 365×384; field of view 300×400 mm; slice 
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width 5 mm) acquired with and without Spectral Attenuated Inversion Recovery fat 
suppression in order to allow segmentation of aortic wall. CTA was performed using a 320-
multidetector (Edinburgh: Aquilon ONE; Toshiba) or 64-multidetector CT scanner (Glasgow: 
Brilliance 64; Philips). 
 
Biomechanical analyses at baseline 
The methods used are described in detail elsewhere11 and also in the Supplementary Material. 
Briefly, after 3D reconstruction of the MRI and CTA data, the computational biomechanics 
processes are fully automated and output the required data.11 Patient-specific baseline blood 
pressure is applied to the inner surface of the lumen and the AAA geometry is fixed from 
movement in all directions in the proximal and distal regions to represent attachment to the 
proximal non-aneurysmal aorta and distally to the iliac arteries (Figure S1).10-18 The 3D 
reconstruction method can introduce user variability, however we11 and others26 have 
demonstrated that resulting biomechanical data are relatively insensitive to variations in 3D 
reconstruction. Our algorithm calculates maximum principal wall stress, wall strength27 and 
ABR.17 ABR is the ratio of local wall stress to local wall strength and we use the 99th centile 
of ABR as the final patient-specific metric, which we refer to as peak ABR throughout this 
study. We also investigated the spatial locations of peak ABR in each case (Figure S3).  
 
Statistical analysis 
The sample size was calculated for the original MA3RS Study.25 The primary endpoint was 
the composite of two aneurysm-related events, AAA repair and/or rupture. Biomechanical 
and statistical analyses were performed independently to minimize bias, with the primary 
biomechanical analysts (BJD, NB) blinded to the clinical endpoint data and all statistical 
analyses performed by independent analysts (MS, ASVS). As with the original MA3RS 
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Study, treating clinicians were blind to all research imaging and image processing data and 
their decision to intervene was unbiased by the study. Categorical data are presented as 
counts and percentage, whereas continuous data are presented as mean ± standard deviation 
(SD). Correlations were determined using two-sided Pearson’s or Spearman’s tests. Peak 
ABR and PWS were logarithmically transformed and we stratified our cohort by tertiles of 
peak ABR. We used ANOVA to determine differences in baseline risk factors and Kaplan-
Meier analysis to evaluate the time to event for each group. To assess the power of ABR to 
predict the primary endpoint, a Cox regression model was developed with variables 
iteratively included to the model.  
We developed three models:  
 Model 1 = unadjusted;  
 Model 2 = Model 1 plus age (y), sex and baseline diameter measured with ultrasound 
(mm);  
 Model 3 = Model 2 plus smoking status, systolic and diastolic blood pressure 
(mmHg), diabetes and uptake of USPIO.  
Aneurysm growth rate was determined from serial ultrasound measurements using a linear 
regression model fit to all available ultrasound data, with the slope used to determine growth 
rate per year. Aneurysm growth rate was then investigated as a post hoc outcome. Finally, we 
also investigated the categorical net reclassification index (NRIcat) using two different risk 
thresholds (0.5 and 0.8), then the continuous NRI (NRIcont) and finally the integrated 
discrimination index (IDI). The NRI quantifies how well a new model reclassifies subjects, 
either appropriately or inappropriately, as compared to an old model. Whereas, the IDI 
quantifies the capacity of a marker to predict a binary outcome of interest. Statistical 





Baseline characteristics of the cohort are shown in Table 1. Of the 1942 patients originally 
screened, 295 were included in the study (Figure 1), with more detail provided in the 
Supplementary Material. We excluded 14% (47/342) of the original MA3RS cohort due to 
absent or inadequate CTA, however our final cohort had similar baseline characteristics to 
the original cohort (see Supplementary Material, Table S2).  
 
Baseline biomechanical assessment 
We divided the cohort into tertiles of peak ABR as follows: Tertile 1 = 0.16-0.36; Tertile 2 = 
0.37-0.49; Tertile 3 = 0.50-2.32. Baseline diameter was different across the tertiles of peak 
ABR (p=0.008), being lowest in the lowest ABR tertile (Table 1). The proportion of women 
increased across the ABR tertiles (p<0.001). All biomechanical data are shown in Table 2 
with an illustrative case shown in Figure 2. There were a number of significantly different 
biomechanical variables across ABR tertiles (Table 2).  
 
Increasing baseline diameter was correlated weakly with both peak ABR (r=0.158, p=0.006) 
and PWS (r=0.135, p=0.019). ABR and PWS were correlated with both wall thickness 
(r=0.274, p<0.001 and r=0.278, p<0.001, respectively) and ILT thickness (r=0.194, p<0.001 
and r=0.345, p<0.001, respectively). Furthermore, ABR and PWS were both correlated with 
AAA wall strength (r=-0.274, p<0.001 and r=0.202, p<0.001, respectively; Figure S2). The 
location of peak ABR was variable throughout the cohort, however, there was a clear 
tendency to occur on the left side (49%) compared to the right (23%), posterior (16%), or 
anterior (12%). Also, the left medial region was the most common location (15%), followed 
by the posterior medial (9%), anterior medial (7%) and posterior left medial regions (7%; 
Table S3 and S4). However peak ABR also occurred outside the zone of maximum diameter 
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(medial region) in a about half the cases, more proximal in 30% and more distal in 22%.  
Interestingly, heat maps of location and peak ABR show that the right medial region 
experience the greatest magnitude of ABR (Figure S4).  
 
Clinical follow-up and the primary endpoint 
Participants were followed up for a mean of 848±379 days. The mean growth rate of the 
cohort was 2.84±2.54 mm/year (n=249; see Supplementary Material) and was similar across 
ABR tertiles (p=0.349; Table 1).   
 
Rupture (n=13) or repair (n=102) occurred in 115 (41%) cases; 98 repairs were elective, of 
which 40 were endovascular aneurysm repair and the remainder were open repair. Cases with 
an aneurysm-related event more commonly had peak ABR on the left side (52%) over the 
right (21%), posterior (15%), or anterior sides (12%). Again, the left medial region was the 
dominant location of peak ABR (17%) in cases with an aneurysm-related event; 31% of 
ruptures (4/13) occurred on the left medial wall (Table S3).  
 
The mean (standard error) log-transformed peak ABR of cases that had a clinical event was 
16% higher than those without (-0.86 (0.03) vs. -0.74 (0.04); p=0.0138; Figure 3A). The 
number of repairs increased from low (n=24) to medium (n=34) and high (n=44) ABR tertiles 
(p=0.010), however the number of ruptures did not (p=0.3575; Table 3). In total, there were 
39 (13%) deaths of which 31% (12/39) were AAA-related (11 from AAA rupture and one 





Duration of follow-up was similar for each tertile (p=0.346). As shown in the Kaplan Meier 
analysis (Figure 3B), repair or rupture occurred more frequently in those with higher peak 
ABR (log rank p=0.0089). Cox regression (Table 4) revealed peak ABR tertiles to be 
independently predictive of the primary endpoint after adjusting for age, sex, baseline 
diameter, smoking status, systolic and diastolic blood pressure, diabetes, and inflammation of 
the AAA wall. In a post hoc analysis of AAA growth rate and using an annual growth rate of 
2.5 mm/y as a threshold for above average growth,28 we found that for unadjusted data, ABR 
was associated with AAA growth rate (Model 1 = HR 1.51, 95% CI 1.29-1.77, p<0.001) but 
this association lost significance after adjustment for confounding factors (including baseline 
diameter, smoking and diabetes) (Model 2 = HR 1.58, 95% CI 0.73-3.41, p=0.248; Model 3 = 
HR 1.32, 95% CI 0.49-3.53, p=0.586) (Figures S5-7).   
 
At a risk threshold of 0.5 the NRIcat value was 0.011 (95% CI, -0.064-0.086; p=0.769) with 8 
cases reclassified up to a higher risk and 23 reclassified down to a lower risk, whereas at a 
threshold of 0.8, the NRIcat value was 0.066 (95% CI, -0.011-0.142; p=0.093) with 16 cases 
reclassified up and 7 reclassified down. These NRIcat data suggests that 1.1% and 6.6% of 
cases with outcome are more likely to move up a risk category rather than down, respectively 
(see Supplementary Material, Figures S8-11). The NRIcont, which assesses whether change in 
predicted risk is in the correct direction, was 0.327 (95% CI, 0.095-0.560; p=0.006) and the 
IDI was 0.023 (95% CI, 0.005-0.042; p=0.015).  
 
DISCUSSION 
Estimating the likelihood of abdominal aortic aneurysm rupture has major potential clinical 
benefit. Over recent decades, computational biomechanics methods have been the focus of 
much research, although there remains no strong evidence that such risk assessment methods 
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provide any benefit to the patient. Here we report the first and largest prospective clinical 
study to test if the aneurysm biomechanical ratio (ABR) can help stratify patients. We show 
that the peak ABR computed at baseline is a major predictor of repair or rupture, independent 
of all risk factors, including age, sex, aneurysm diameter and smoking. Our findings suggest 
that biomechanical risk profiling at baseline using combined CTA and MRI could help 
inform clinical decisions about the timing of elective repair. 
 
There has been much recent effort in contemporary 3D tools and image-based AAA 
assessment methods.10,11,29,30 Importantly for clinicians, current image-based biomechanical 
approaches to AAA rupture risk are straightforward to implement and do not require 
significant specialist training. In fact, within hours an individual with knowledge of AAA and 
basic computing skills can be trained in such frameworks, and as all data besides the 3D 
reconstruction are automatic and thus insensitive to user-variation, biomechanical data are 
repeatable.11 Once trained, the 3D reconstruction process takes < 1 hour and as with most 
tasks, this reduces with familiarity, so that even a novice user with no previous AAA 3D 
reconstruction experience can reproduce ABR to within 5% of expert results.11 Therefore, 
expertise in computational biomechanics is not a barrier to translation. 
 
Here we have shown that patients with high peak ABR at baseline were more likely to have 
an aneurysm-related event in a cohort of patients with extended follow up, where the treating 
clinician was unaware of the biomechanical findings and where ABR was adjusted for 
clinical risk factors including AAA diameter. This blinding and adjustment is a major 
strength as AAA diameter and sex currently inform the timing of elective repair: peak ABR 
was independently predictive of the primary outcome. Therefore, we also evaluated how peak 
ABR might alter the classification of patients who should be offered elective AAA repair. For 
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thresholds of 0.5 and 0.8 peak ABR, the categorical NRI was 1.1% (p=0.796) and 6.6% 
(p=0.093), respectively, but the continuous NRI was higher and significant at 32.7% 
(p=0.006). Reclassification measures that are independent of the choice of cut-off, such as the 
continuous NRI, are perhaps more appropriate as they are not sensitive to arbitrary risk 
thresholds, however categorical NRI are often easier to interpret. The integrated 
discrimination index (IDI) was modest, showing a 2.3% increase through the addition of peak 
ABR, however the finding was significant (p=0.015) and similar IDI increases of 2-3% have 
been reported in other cardiovascular studies that assessed the value of new risk markers in 
larger cohort sizes.31 
  
In contrast to our promising data, a recent retrospective study32 of 175 intact, 11 symptomatic 
and 45 ruptured AAAs, reported no added value of biomechanical indices in risk assessment 
using commercially available software (A4research™). They used ROC-analysis to 
determine that various combinations of biomechanical data did not offer improvement over 
diameter alone. However, unlike our methods, they relied on assumptions of AAA wall 
thickness and material properties for both the AAA wall and ILT.  
 
Wall thickness has a strong influence on wall stress and subsequent biomechanical metrics. 
We measured large inter- and intra-variation in wall thickness in our cohort, and previous 
work has shown the influence of wall thickness on PWS.33 Therefore, variation in AAA wall 
thickness exists and should be included into biomechanical models (see Supplementary 
Material, Tables S5-7). However, the requirement for wall thickness presents initial problems 
if trying to implement the ABR into the clinic as MRI is not routine in AAA management and 
using CTA alone for wall thickness measurement is not straightforward, except in the 
uncommon situation when intraluminal thrombus is absent.33 The MA3RS Study showed that 
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the uptake of USPIO on MRI predicts growth and clinical outcome.24 As such, MRI could 
serve (at least) two roles in contemporary AAA care; quantify inflammation via USPIO and 
provide wall thickness data.  
 
Our study has several further strengths. To the best of our knowledge, this is the first 
prospective study of AAA biomechanical methods and has used a well-planned clinical trial 
with a high predicted34 and actual event rate (41%)24 which was 39% in this current study. 
This study was designed to evaluate the role of peak ABR in aneurysm-related events. It is 
clear from our study that those with high baseline ABR are more likely to have a future 
aneurysm-related event (Figure 3B). We also observed the anatomical location of peak ABR 
across the AAA to be variable, as is the area of peak ABR. However, we noted a clear 
propensity for peak ABR to occur on the left lateral wall (49%), or more specifically, the left 
lateral medial wall, in both intact (14%) and cases that ruptured (31%) or needed repair 
(13%). In the seminal work of Darling et al.8 they report that 74% of cases ruptured into the 
retroperitoneum, with 33% on the left posterior-lateral and 26% on the right posterior-lateral 
side. In our previous work,15 we also observed the location of rupture to be the left posterior-
lateral region, with this location predicted by our biomechanical simulation using imaging 
acquired four months before rupture. Given the potential utility of ABR demonstrated in this 
study, future studies will evaluate whether additional information about the anatomical 
location, gradient of ABR or extent of raised ABR would increase the discrimination of 
future AAA clinical events. These can be studied from our existing database but would 
benefit from validation in a separate cohort.  
 
There are some limitations of our work. First, despite being the largest study of its kind and 
although we examined 295 patients, due to unforeseen logistical obstacles we lost 47 cases 
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due to missing CTA (n=31) and some due to poor quality CTA (n=16). The study was 
underpowered to assess the impact of ABR on aneurysm rupture alone, but is powered for the 
composite of rupture and/or repair. Second, as discussed earlier, MRI is not routine in AAA 
and as such, our methods would incur an additional cost to implement clinically. However, 
the cost of a single MRI is considerably less than the cost of (unnecessary) intervention.35 
Third, we did not include the aortic wall calcifications in our study as they introduce further 
uncertainty. Li et al36 included calcifications and found that they increased wall stress by 14% 
(range 2-27%, p<0.01). However, others have reported the opposite, with reductions in wall 
stress from 10-59%.37 Fourth, the estimation of wall strength27 depends in part on the family 
history of AAA, which may not be precise since it is subject to recall and other biases, such 
as premature mortality. Fifth, there was no precise protocol for the timing of elective repair, 
which was left to clinical discretion, although the treating clinician had no knowledge of 
either USPIO uptake or ABR: the study data collection did not include the exact reason(s) 
prompting the timing of elective repair. Finally, our methods would benefit from external 
validation in an independent dataset before recommendations can be made to modify 
guidelines.    
 
CONCLUSIONS 
We have shown for the first time that the aneurysm biomechanical ratio independently 
predicted the combined outcome of abdominal aortic aneurysm repair or rupture. 
Furthermore, the aneurysm biomechanical ratio may prove to be a better predictor of 
aneurysm-related events than maximum diameter. Our data are encouraging and a larger 
prospective trial should be undertaken to verify our findings and determine if such methods 
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Table 1: Baseline characteristics of the cohort stratified into peak aneurysm biomechanical 
ratio (ABR) tertiles. Data are mean  standard deviation unless stated otherwise and p-values 












 (n=98) p-value 
Characteristics     
 
   Male, n (%) 257 (87.1) 96 (96.9) 86 (87.8) 75 (76.5) <0.001 
   Age, y 73.7  7.2 73.4  6.9 73.6  7.8 74.0  6.9 0.837 
   Smoking status     0.772 
      Current, n (%) 85 (28.8) 30 (30.3) 33 (33.7) 22 (22.4)  
      Previous, n (%) 171 (58.0) 59 (59.6) 53 (54.1) 59 (60.2)  
      Never, n (%) 39 (13.2) 10 (10.1) 12 (12.2) 17 (17.3)  
   Alcohol, units*   7.5  11.1 7.1  11.7 8.7  11.4 6.7  10.2 0.436 
   Weight, kg 81.3  14.0 81.9  12.5 80.9  13.8 81.1   15.6 0.855 
   Height, cm 171.5   8.3 173.1   6.9 171.7  8.4 169.8  9.1 0.021 
   Systolic blood pressure, mmHg 139.8  24.6 134.2  17.6 137.9  20.0 147.2  24.6 <0.001 
   Diastolic blood pressure, mmHg 81.4  11.7 79.2  9.2 81.4  10.9 83.7  11.7 0.012 
   Heart rate, bpm* 70.5  11.4 69.2  9.2 70.2  9.9 72.0  11.4 0.153 
   Hypertension, n (%) 213 (72.2) 70 (70.7) 72 (73.5) 71 (72.4) 0.909 
Aneurysm      
   AAA diameter, mm 49.0  6.9 47.3  6.1 50.1  7.7 49.6  6.7 0.008 
   Growth rate, mm/y 2.84  2.54 2.61  2.49 2.80  2.21 3.17  2.89 0.349 
   Positive USPIO† uptake, n (%)* 124 (42.6) 43 (43.9) 42 (44.2) 39 (39.8) 0.786 
Medical history      
   Diabetes, n (%) 42 (14.2) 20 (20.2) 13 (13.3) 9 (9.2) 0.082 
   Hypercholesterolemia, n (%) 226 (76.6) 78 (78.8) 77 (78.5) 71 (72.4) 0.492 
   Ischaemic heart disease, n (%) 112 (38.0) 40 (40.4) 46 (46.9) 26 (26.5) 0.011 
   Peripheral vascular disease, n (%) 58 (19.7) 22 (22.2) 23 (23.5) 13 (13.3) 0.146 
   Cerebrovascular disease, n (%) 39 (13.2) 18 (18.2) 10 (10.2) 11 (11.2) 0.198 
   Family history of AAA, n (%)‡ 52 (17.6) 4 (4.0) 13 (13.3) 35 (35.7) <0.001 
* Missing data: Growth rate, n=46 (Details provided in the Supplementary Material); alcohol, n=2; heart rate, 
n=4; USPIO uptake, n=4. 
† USPIO = ultrasmall superparamagnetic particles of iron oxide. 




Table 2: Baseline biomechanical data of the cohort stratified into peak aneurysm 
biomechanical ratio (ABR) tertiles. Data are mean  standard deviation and p-values are from 
ANOVA. 






High ABR p-value 
Aneurysm biomechanical ratio 0.49  0.27 0.30  0.05 0.43  0.04 0.74  0.34 <0.001 
Peak wall stress, MPa 0.35  0.15 0.25  0.04 0.33  0.06 0.48  0.18 <0.001 
Wall thickness      
   Mean, mm 2.00  0.36 2.09  0.40 1.96  0.30 1.89  0.29 <0.001 
   Maximum, mm 3.38  1.16 3.60  1.72 3.24  0.74 3.19  0.72 0.037 
   Minimum, mm 1.19  0.25 1.27  0.21 1.20  0.24 1.11  0.25 <0.001 
ILT thickness      
   Mean, mm 4.06  2.08 4.50  2.05 4.05  2.15 3.61  1.97 0.011 
   Maximum, mm 14.76  6.91 15.73  5.48 14.65  7.17 13.90  7.82 0.173 
   Minimum, mm 0.90  0.11 0.93  0.15 0.89  0.08 0.89  0.09 0.020 
Wall strength      
   Mean, MPa 0.76  0.13 0.80  0.09 0.76  0.13 0.71  0.16 <0.001 
   Maximum, MPa 1.04  0.11 1.08  0.06 1.05  0.09 0.98  0.13 <0.001 





Table 3: Clinical outcomes of patients stratified into peak aneurysm biomechanical ratio 
(ABR) tertiles. Data are sample size (%) or mean  standard deviation and p-values are from 







High ABR p-value 
Mean follow-up, y 2.98  0.51 3.04  0.48 2.91  0.58 0.346 
Repair or rupture 30* (25.4) 36 (31.6) 49 (43.0) 0.010 
   Repair 24 (24.2) 34 (34.7) 44 (44.9) 0.001 
   Rupture 6* (6.1) 2 (2.0) 5 (5.1) 0.358 


















Table 4: Cox regression analysis for each of the three models and the primary endpoint of 
repair and/or rupture. 
 Hazard ratio (95% CI) p-value 
Model 1    
   Aneurysm biomechanical ratio, tertiles 1.42 (1.13-1.79) 0.003 
Model 2   
   Aneurysm biomechanical ratio, tertiles 1.37 (1.07-1.75) 0.014 
   Age, y 0.94 (0.91-0.97) <0.001 
   Gender 1.01 (0.57-1.78) 0.977 
   Baseline diameter, mm  1.08 (1.06-1.10) <0.001 
Model 3   
   Aneurysm biomechanical ratio, tertiles 1.41 (1.09-1.83) 0.010 
   Age, y 0.95 (0.92-0.98) 0.001 
   Gender 0.90 (0.50-1.62) 0.717 
   Baseline diameter, mm 1.08 (1.06-1.11) <0.001 
   Smoker (current), yes/no 1.10 (0.57-2.14) 0.781 
   Smoker (previous), yes/no 0.75 (0.42-1.35) 0.341 
   Diabetes Mellitus, yes/no 0.98 (0.53-1.84) 0.960 
   Systolic blood pressure, mmHg 0.99 (0.97-1.00) 0.025 
   Diastolic blood pressure, mmHg 1.03 (1.01-1.06) 0.005 











Figure 1: Diagram of participant recruitment (left) and computational workflow of the study 
(right). The shaded boxes on the right represent steps that require user-input to the 
computational framework. The computer model uses the finite element method to calculate 
wall stress with patient-specific systolic blood pressure as input, wall thickness 
measurements from merged MRI and CTA, and a computational method independent of 
material properties.11 CTA = computed tomography angiography; MRI = magnetic resonance 




Figure 2: Example biomechanical data produced in the study. (A) Wall thickness is 
measured on registered MRI-CTA and incorporated into the 3D geometry for more accurate 
biomechanical simulations. (B) Maximum principal wall stress (units are Megapascal, MPa) 
is calculated using patient-specific blood pressure measured at the time of baseline imaging. 
(C) Wall strength is calculated using a previous method27 that includes factors shown to 
influence wall strength; patient gender, family history of AAA, local measures of ILT 
thickness and ratios of local AAA diameter to proximal non-aneurysmal diameter. (D) 
Aneurysm biomechanical ratio (ABR) is the dimensionless ratio of local wall stress and wall 
strength and is computed pointwise on the geometry. All data are automatically reported for 












Figure 3: (A) Log-transformed aneurysm biomechanical ratio (ABR) and the primary 
endpoint. ABR was higher in cases that needed AAA repair or experienced rupture (mean  
standard error Intact vs Ruptured/Repaired; -0.86  0.03 vs. -0.74  0.04; p=0.0138). (B) 
Kaplan Meier analysis showing time to endpoint. Cases with high ABR at baseline (tertile 3) 
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 Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the 
title or the abstract 
1  
(b) Provide in the abstract an informative and balanced summary of 
what was done and what was found 
2  
Introduction   
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported 
4  
Objectives 3 State specific objectives, including any prespecified hypotheses 5  
Methods   
Study design 4 Present key elements of study design early in the paper 6  
Setting 5 Describe the setting, locations, and relevant dates, including 
periods of recruitment, exposure, follow-up, and data collection 
6  30 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
6 30 
(b) For matched studies, give matching criteria and number of 
exposed and unexposed 
NA  
Variables 7 Clearly define all outcomes, exposures, predictors, potential 





8*  For each variable of interest, give sources of data and details of 
methods of assessment (measurement). Describe comparability of 
assessment methods if there is more than one group 
7,8  
Bias 9 Describe any efforts to address potential sources of bias 7 44 
Study size 10 Explain how the study size was arrived at 7  
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
8  
Statistical methods 12 (a) Describe all statistical methods, including those used to control 
for confounding 
7,8  
(b) Describe any methods used to examine subgroups and 
interactions 
8  
(c) Explain how missing data were addressed 10,  
Table 1 
 
(d) If applicable, explain how loss to follow-up was addressed  33 
(e) Describe any sensitivity analyses  44 
Results   
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, confirmed 
eligible, included in the study, completing follow-up, and analysed 
9  
(b) Give reasons for non-participation at each stage NA  
(c) Consider use of a flow diagram Figure 1  
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders 
Table 1  
(b) Indicate number of participants with missing data for each 
variable of interest 
10 33 
(c) Summarise follow-up time (eg, average and total amount) 10  
Outcome data 15* Report numbers of outcome events or summary measures over time 10  
  
30 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-
adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and why 
they were included 
11-13 39-43 





(c) If relevant, consider translating estimates of relative risk into 
absolute risk for a meaningful time period 
NA  
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses 
 36-48 
Discussion   
Key results 18 Summarise key results with reference to study objectives 12  
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and magnitude 
of any potential bias 
14  
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from similar 
studies, and other relevant evidence 
WTPA  
Generalisability 21 Discuss the generalisability (external validity) of the study results 14  
Other information   
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which the 
present article is based 
15  
 
Study design, setting and population 
This was a multicentre cohort study performed as part of the MA3RS Study 
(ISRCTN76413758). Patients were identified from the clinical aneurysm surveillance 
database at the Royal Infirmary Edinburgh, Western Infirmary Glasgow and Forth Valley 
Royal Hospital and supplied with information about the study. From the original screening 
(Figure 1), patients were selected based on inclusion criteria of age ≥ 40 years, aneurysm 
diameter ≥ 40 mm measured by ultrasound (inner-to-inner AAA wall, anterior-posterior), and 
under ultrasound surveillance as part of routine care. Patients were excluded if surgical repair 
was already planned, they had an inflammatory and/or saccular aneurysm, connective tissue 
disorder, women of childbearing potential, renal failure, contraindication to magnetic 
resonance imaging (MRI) or ferumoxytol (a contrast agent of ultrasmall superparamagnetic 
particles of iron oxide (USPIO) required for additional imaging studies), or inadequate image 




From 1942 patients, 1201 were ineligible due to AAA diameter < 40 mm (n=920), other 
major illness (n=163), contraindication to scan (n=88), planned surgery (n=14), other (n=16). 
Of the 741 eligible patients, 288 declined, 86 were uncontactable and 6 could not be 
recruited. Of the resulting 361 patients, 16 were unable to tolerate MRI at time of imaging 
and 3 had an aneurysm that was too small when imaged with CTA. This left 342 patients who 
gave informed consent. Cases were then further excluded if the CTA data were missing, 
incomplete or of poor quality (e.g. imaging artefacts) (n=47). Our cohort had similar 
characteristics to the original cohort (Table S2). 






Characteristics   
   Male, % 87.1 85.4 
   Age, yrs (SD) 73.7 (7.2) 73.1 (7.2) 
   Smoking status  
 
      Current, % 28.8 29.5 
      Previous, % 58.0 57.0 
      Never, % 13.2 13.5 
   Systolic blood pressure, mmHg 139.8 (24.6) 139.6 (21.2) 
   Diastolic blood pressure, mmHg 81.4 (11.7) 81.4 (10.8) 
   Heart rate, bpm* 70.5 (11.4) 70.7 (10.1) 
   Hypertension, % 72.2 71.9 
Aneurysm   
   AAA diameter, mm (SD) 49.0 (6.9) 49.6 (7.7) 
   Rupture/repair, % 38.9 40.9 
   Rupture, % 4.4 5.0 
   Rupture, % 34.6 36.8 
Medical history   
   Diabetes, % 14.2 13.7 
   Hypercholesterolemia, % 76.6 75.1 
   Ischaemic heart disease, % 38.0 36.5 
   Peripheral vascular disease, % 19.7 19.3 
   Cerebrovascular disease, % 13.2 13.5 




Study protocol and follow-up 
Within six weeks of the initial screening ultrasound, participants underwent full clinical 
assessment, including blood pressure measurement, MRI and computed tomography 
angiography (CTA). MRI protocols have been reported elsewhere and CTA was per routine 
practice. Patients were then reviewed every six months for a minimum of 24 months, which 
consisted of maximum anterior-posterior diameter measured by ultrasound at dedicated 
screening clinics, as well as structured collection of follow-up data and clinical events. The 
entire protocol describing the study design, collection of clinical data (imaging protocols and 
data analyses), criteria for surgery and clinical follow-up have been reported previously.  
 
Biomechanical analyses at baseline 
Briefly, our process begins by spatially registering the MRI and CTA together into a single 
image dataset. Aortic wall thickness is measured throughout the aneurysm on the merged 
images. The aneurysm, including the intraluminal thrombus (ILT), is semi-automatically 
segmented and reconstructed into three dimensions (3D) using well-established algorithms, 
after which the non-uniform AAA wall is generated according to the wall thickness data.  
 
After 3D reconstruction, the computational biomechanics processes are fully automated. This 
process involves creating a volume mesh of finite elements and assigning material properties; 
these arbitrary properties have no effect on the simulation and are simply required to aid the 
computation (see Table S5, for further details on the influence of material properties). 
Patient-specific baseline blood pressure is applied to the inner surface of the lumen and the 
AAA geometry is fixed from movement in all directions in the proximal and distal regions to 
represent attachment to the proximal non-aneurysmal aorta and distally to the iliac arteries 
(Figure S1).  
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In addition, we investigated the spatial locations of peak ABR in each case by dividing the 
AAA into regions of interest: posterior, anterior, left and right lateral, and also proximal, 
medial and distal regions (Figure S3).  
 
Boundary Conditions for Computational Model  
 
Figure S1: Illustration of boundary conditions used. The AAA geometry was fixed from all 
movement in the proximal and distal regions to represent attachment to the proximal non-
aneurysmal aorta and attachment distally to the iliac arteries. Patient-specific blood pressure 
was applied to the inner surface of the intraluminal thrombus. This is a widely implemented 
computational approach in biomechanical analyses.   
 
Missing Growth Rate Data 
Growth rate was not available in 46 cases, either due to repair prior to follow-up ultrasound 
(n=37) or death (AAA rupture, n=2; myocardial infarction, n=1; cancer, n=1; other cause, n=1). 
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A further three cases of large AAA in elderly men were not repaired as they were unfit for 





Correlations Between Aneurysm Biomechanical Ratio, Peak Wall Stress and Factors 
That Influence Biomechanical Data 
 
Figure S2: Left column; correlations between aneurysm biomechanical ration (ABR) and (a) 
baseline diameter, (c) mean wall thickness, (e) mean ILT thickness and (g) mean wall 
strength. Right column; correlations between peak wall stress (PWS) and (b) baseline 




Location of Peak Aneurysm Biomechanical Ratio 
We classified the location of peak aneurysm biomechanical ratio (ABR) for each case 
according to Figure S3 and the resulting locations are shown in Tables S3-4, and Figure S4. 
 
Figure S3: Regions used to mark the location of peak ABR on each AAA. We divided the 
AAA into proximal, medial and distal with each region accounting for one third of the 
aneurysm surface area, as shown on the left. We also divided the cross-section as shown on 




Figure S4: Heat map of log-transformed ABR for each region of interest. The magnitude of 
ABR was greatest in the right medial region. 
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Table S3: Locations of peak ABR in the entire cohort as well as for those with and without a 
clinical event. Data shown as n (%). 
Location of peak ABR All cases Intact Repaired Ruptured 
Left Medial 44 (14.9) 25 (13.9) 15 (13.2) 4 (30.8) 
Posterior Medial 25 (8.5) 16 (8.9) 6 (5.3) 3 (23.1) 
Anterior Medial 19 (6.4) 12 (6.7) 7 (6.1) - 
Posterior Left Medial 19 (6.4) 12 (6.7) 6 (5.3) 1 (7.7) 
Anterior Left Medial  17 (5.8) 10 (5.6) 7 (6.1) - 
Posterior Left Distal 16 (5.4) 9 (5%) 7 (6.1) - 
Posterior Right Proximal  16 (5.4) 9 (5%) 7 (6.1) - 
Posterior Proximal 15 (5.1) 9 (5%) 5 (4.4) 1 (7.7) 
Left Proximal 14 (4.7) 8 (4.4) 5 (4.4) 1 (7.7) 
Left Distal 13 (4.4) 8 (4.4) 5 (4.4) - 
Anterior Proximal 11 (3.7) 6 (3.3) 5 (4.4) - 
Anterior Left Proximal  10 (3.4) 6 (3.3) 4 (3.5) - 
Posterior Right Distal  10 (3.4) 6 (3.3) 3 (2.6) 1 (7.7) 
Right Medial 9 (3.1) 6 (3.3) 3 (2.6) - 
Posterior Left Proximal 9 (3.1) 6 (3.3) 3 (2.6) - 
Anterior Right Proximal  8 (2.7) 6 (3.3) 2 (1.8) - 
Posterior Distal 8 (2.7) 6 (3.3) 2 (1.8) - 
Anterior Right Medial 7 (2.4) 5 (2.8) 2 (1.8) - 
Anterior Distal  5 (1.7) 3 (1.7) 2 (1.8) - 
Anterior Right Distal 5 (1.7) 3 (1.7) 1 (0.9) 1 (7.7) 
Right Proximal 5 (1.7)  3 (1.7) 2 (1.8) - 
Right Distal 4 (1.4) 3 (1.7) 1 (0.9) - 
Anterior Left Distal  3 (1.0) 2 (1.1) 1 (0.9) - 










Table S4: Locations of peak ABR across the tertiles of peak ABR. Data shown as n (%). 







Left Medial 11 (11.1) 15 (15.3) 18 (18.4) 
Posterior Medial 8 (8.1) 6 (5.3) 8 (8.2) 
Anterior Medial 5 (5.1) 6 (6.1) 8 (8.2) 
Posterior Left Medial 5 (5.1) 6 (6.1) 8 (8.2) 
Anterior Left Medial 8 (8.1) 5 (5.1) 4 (4.1) 
Posterior Left Distal 5 (5.1) 6 (6.1) 5 (5.1) 
Posterior Right Proximal 5 (5.1) 7 (7.1) 4 (4.1) 
Posterior Proximal 8 (8.1) 3 (3.1) 4 (4.1) 
Left Proximal 7 (7.1) 3 (3.1) 4 (4.1) 
Left Distal 5 (5.1) 5 (5.1) 3 (3.1) 
Anterior Proximal 5 (5.1) 3 (3.1) 3 (3.1) 
Anterior Left Proximal 3 (3.0) 4 (4.1) 3 (3.1) 
Posterior Right Distal  3 (3.0) 2 (2.0) 5 (5.1) 
Right Medial 5 (5.1) 2 (2.0) 2 (2.0) 
Posterior Left Proximal 3 (3.0) 4 (4.1) 2 (2.0) 
Anterior Right Proximal 2 (2.0) 4 (4.1) 2 (2.0) 
Posterior Distal 2 (2.0) 3 (3.1) 3 (3.1) 
Anterior Right Medial - 4 (4.1) 3 (3.1) 
Anterior Distal  2 (2.0) 2 (2.0) 1 (1.0) 
Anterior Right Distal  2 (2.0) - 3 (3.1) 
Right Proximal 2 (2.0) 2 (2.0) 1 (1.0) 
Right Distal 2 (2.0) - 2 (2.0) 
Anterior Left Distal - 2 (2.0) 1 (1.0) 






Post Hoc Analysis of Growth Rate as the Endpoint 
The original composite endpoint was rupture or repair. We also performed a post hoc analysis 
using a generalised model with growth rate as the endpoint. The same predictors were then 
used as in the original Cox Survival analysis: Aneurysm Biomechanical Ratio, age, sex, AAA 
size (at baseline), smoking status, systolic blood pressure, diastolic blood pressure, diabetes 
mellitus and USPIO uptake, resulting in three models as before. Each regression model then 
created a binary endpoint depending on the growth rate threshold applied. Here we chose 2.5 
mm/y which is the slightly greater than the mean growth rate of small AAAs1 and slightly 
below the mean growth rate determined in our cohort (2.84 mm/y). We then run each model 
ten times with an incremental increase in AAA growth rate by 0.5 mm/yr. Guidelines 
recommend intervening when growth rate exceeds 10 mm/y, however very few cases which 
such growth exist in our cohort (n=3), so we have limited our analysis to annual growth of 5 
mm/y.  
 
Using a 2.5 mm/y threshold for growth rate, we find the following odds ratios.  
 Model 1: OR 1.51 (1.29-1.77); p<0.001 
 Model 2: OR 1.58 (0.73-3.41); p=0.248 
 Model 3: OR 1.32 (0.49-3.53); p=0.586 
 
The full analyses for each model are presented in Figures S5-7. In essence, ABR predicts 





Figure S5: Aneurysm biomechanical ratio as a sole predictor of experiencing annual aortic 




Figure S6: Aneurysm biomechanical ratio as a predictor of experiencing annual aortic growth 
following adjustment for age, gender and baseline AAA diameter from ultrasound 






Figure S7: Aneurysm biomechanical ratio as a predictor of experiencing annual aortic growth 
following adjustment for age, gender, baseline AAA size from ultrasound, smoking status, 







Categorical Net Reclassification Index at 0.5 Risk Threshold 
 
Figure S8: Net reclassification index of our new model at a risk threshold of 0.5, split into peak 
ABR tertiles. The NRIcat value was 0.066 (95% CI, -0.011-0.142; p=0.093) with 16 cases 
reclassified up and 7 reclassified down. 
 
 
Figure S9: Net reclassification index of our new model at a risk threshold of 0.5, split into 




Categorical Net Reclassification Index at 0.8 Risk Threshold 
 
Figure S10: Net reclassification index of our new model at a risk threshold of 0.8, split into 
peak ABR tertiles. NRIcat value was 0.011 (95% CI, -0.064-0.086; p=0.769) with 8 cases 
reclassified up to a higher risk and 23 reclassified down to a lower risk. 
 
Figure S11: Net reclassification index of our new model at a risk threshold of 0.8, split into 




The Influence of Computational Methods 
We also wanted to explore and understand the influence of modelling approach on the 
biomechanical data of our cohort. In vivo patient-specific material properties are unknown 
and introduce major uncertainty2 without modelling the AAA as statically determinate3-5 or 
using inverse modelling methods.6 Therefore, in order for biomechanical methods to be used 
with confidence in the clinic, the only practical approach is to remove material properties 
from the solution completely, similar to our approach in this study.  
 
In order to demonstrate the effect of common modelling assumptions in AAA biomechanical 
analyses, we studied a sub-group from our cohort (n=15) using commercial methods 
(A4research™, VASCOPS GmbH, Graz, Austria) that have been widely adopted (e.g. 
Leemans et al.7). By implementing the statically determinate approach, we tested the effect of 
patient-specific wall thickness compared to the variable wall model implemented in 
A4research™. We found that maximum principal wall stresses (i.e. PWS) were on average 
24% higher (range 4-48%, p=0.0002; Table S5) when including patient-specific wall 
thickness.  
 
We also compared PWS computed using the common assumption of uniform wall thickness 
(1.5 mm) compared to the patient-specific geometry with measured wall thickness, again 
using the statically determinate approach. Wall stress varied by an average of 11% (range 0-
39%, p=0.3462; Table S6), with similarly large percentage differences also reported 
previously.8  
 
Finally, we tested the effect of simulation strategy by comparing the statically determinate 
linear simulations to the commonly used non-linear method (also implemented in 
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A4research™). We found PWS to differ on average by 18% (range 1-34%, p=0.0140; Table 
S7) with 10/15 cases experiencing ≥ 10% difference.  
 
Therefore, our data indicate that even with a thorough understanding of the level of 
uncertainty in computational simulations,9 it may not be appropriate to use ambiguous 
biomechanical models to assess potentially life-threatening aneurysms. Unknown material 
properties and wall thickness represent major obstacles to current biomechanical methods, 
hence why we have developed our approach. Importantly, others are also developing methods 
of calculating aortic wall stress without material properties5, 10 or with estimates of wall 





Table S5: Effect of reconstruction process on the maximum principal wall stress. Data shows 
the wall stress computed using the variable wall thickness algorithm of A4research™ and the 
patient-specific measurements used here. We used the same material properties, pressure 
loading and constraints for both simulations. We calculated the percentage change relative to 
our data. The difference in wall stress was significant (p=0.0002) using a two-sided Mann-
Whitney test. 
 
Max principal stress (MPa) 
 
Case  A4research™ Our approach % change 
1 0.223 0.243 8.1 
2 0.232 0.287 19.2 
3 0.292 0.412 29.1 
4 0.227 0.438 48.1 
5 0.210 0.312 32.7 
6 0.200 0.242 17.5 
7 0.213 0.254 16.1 
8 0.227 0.218 3.9 
9 0.171 0.228 25.3 
10 0.176 0.229 23.3 
11 0.152 0.231 34.1 
12 0.183 0.245 25.1 
13 0.217 0.242 10.4 
14 0.210 0.286 26.8 
15 0.151 0.235 35.9 
Mean 0.206 0.276 23.7 
SD 0.036 0.057 11.7 
Min 0.151 0.228 3.9 










Table S6: Effect of wall thickness on the maximum principal wall stress. Data shows the wall 
stress computed using a typically employed uniformly thick AAA wall (1.5 mm) and that of 
the patient-specific measurements used here. We used the same material properties, pressure 
loading and constraints for both simulations. We calculated the percentage change relative to 
the patient-specific data. The difference in wall stress was not significant (p=0.3462) using a 
two-sided Mann-Whitney test. 
 
Max principal stress (MPa) 
 
Case  Constant Patient-specific % change 
1 0.250 0.243 3.1 
2 0.303 0.287 5.7 
3 0.496 0.412 20.3 
4 0.402 0.438 8.1 
5 0.324 0.312 4.0 
6 0.337 0.242 39.3 
7 0.237 0.254 6.6 
8 0.253 0.218 15.7 
9 0.215 0.228 5.9 
10 0.264 0.229 15.1 
11 0.200 0.231 13.5 
12 0.277 0.245 13.2 
13 0.254 0.242 4.7 
14 0.286 0.286 0.2 
15 0.254 0.235 8.1 
Mean 0.281 0.276 10.9 
SD 0.058 0.057 9.6 
Min 0.200 0.228 0.2 











Table S7: Effect of simulation strategy on the maximum principal wall stress. Data shows the 
wall stress computed using the non-linear material properties implemented in A4research™, 
compared to the statically determinate linear method we use. We used the same geometries 
(both created with A4research™), pressure loading and constraints for both simulations. We 
calculated the percentage change relative to our linear data. The difference in mean wall 
stress was significant (p=0.0140) using a two-sided Mann-Whitney test. 
 
Max principal stress (MPa) 
 
Case  Non-linear Linear % change 
1 0.220 0.223 1.4 
2 0.220 0.232 5.1 
3 0.196 0.292 32.8 
4 0.186 0.227 18.2 
5 0.141 0.210 33.1 
6 0.191 0.200 4.5 
7 0.191 0.213 10.3 
8 0.163 0.227 28.2 
9 0.118 0.171 30.9 
10 0.158 0.176 10.3 
11 0.142 0.152 6.5 
12 0.185 0.183 0.8 
13 0.144 0.217 33.5 
14 0.140 0.210 33.1 
15 0.188 0.151 24.8 
Mean 0.172 0.206 18.2 
SD 0.031 0.036 13.1 
Min 0.118 0.151 0.8 
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